Selected research
Industry Research
Amyloid Peptides Industry Research Report 2026
Market perspective
The global Amyloid Peptides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amyloid Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amyloid Peptides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amyloid Peptides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amyloid Peptides include rPeptide, NovoPro Inc., Genscript, Cambridge Research Biochemicals, Bio-Synthesis, BioLegend, Bachem, AnaSpec, Inc and AmideBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amyloid Peptides market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amyloid Peptides Market by Company
rPeptide
NovoPro Inc.
Genscript
Cambridge Research Biochemicals
Bio-Synthesis
BioLegend
Bachem
AnaSpec, Inc
AmideBio
Amyloid Peptides Segment by Type
Beta-Amyloid Mouse
Beta-Amyloid Human
Beta-Amyloid Rat
Amyloid Peptides Segment by Application
Cerebral Amyloid Angiopathy Research
Lewy Body Dementia Research
Inclusion Body Myositis Research
Cancer Research
Alzheimer's Disease Research
Others
Amyloid Peptides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amyloid Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amyloid Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amyloid Peptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amyloid Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amyloid Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amyloid Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Beta-Amyloid Mouse
- Beta-Amyloid Human
- Beta-Amyloid Rat
Applications
- Cerebral Amyloid Angiopathy Research
- Lewy Body Dementia Research
- Inclusion Body Myositis Research
- Cancer Research
- Alzheimer's Disease Research
- Others
Companies covered
- rPeptide
- NovoPro Inc.
- Genscript
- Cambridge Research Biochemicals
- Bio-Synthesis
- BioLegend
- Bachem
- AnaSpec, Inc
- AmideBio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amyloid Peptides Market Size (2021-2032)
- 2.2.2 Global Amyloid Peptides Sales (2021-2032)
- 2.2.3 Global Amyloid Peptides Market Average Price (2021-2032)
- 2.3 Amyloid Peptides by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Beta-Amyloid Mouse
- 2.3.3 Beta-Amyloid Human
- 2.3.4 Beta-Amyloid Rat
- 2.4 Amyloid Peptides by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cerebral Amyloid Angiopathy Research
- 2.4.3 Lewy Body Dementia Research
- 2.4.4 Inclusion Body Myositis Research
- 2.4.5 Cancer Research
- 2.4.6 Alzheimer's Disease Research
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amyloid Peptides Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amyloid Peptides Sales (g) of Manufacturers (2021-2026)
- 3.3 Global Amyloid Peptides Revenue of Manufacturers (2021-2026)
- 3.4 Global Amyloid Peptides Average Price by Manufacturers (2021-2026)
- 3.5 Global Amyloid Peptides Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amyloid Peptides, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amyloid Peptides, Product Type & Application
- 3.8 Global Manufacturers of Amyloid Peptides, Established Date
- 3.9 Global Amyloid Peptides Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 rPeptide
- 4.1.1 rPeptide Company Information
- 4.1.2 rPeptide Business Overview
- 4.1.3 rPeptide Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 rPeptide Amyloid Peptides Product Portfolio
- 4.1.5 rPeptide Recent Developments
- 4.2 NovoPro Inc.
- 4.2.1 NovoPro Inc. Company Information
- 4.2.2 NovoPro Inc. Business Overview
- 4.2.3 NovoPro Inc. Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 NovoPro Inc. Amyloid Peptides Product Portfolio
- 4.2.5 NovoPro Inc. Recent Developments
- 4.3 Genscript
- 4.3.1 Genscript Company Information
- 4.3.2 Genscript Business Overview
- 4.3.3 Genscript Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Genscript Amyloid Peptides Product Portfolio
- 4.3.5 Genscript Recent Developments
- 4.4 Cambridge Research Biochemicals
- 4.4.1 Cambridge Research Biochemicals Company Information
- 4.4.2 Cambridge Research Biochemicals Business Overview
- 4.4.3 Cambridge Research Biochemicals Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cambridge Research Biochemicals Amyloid Peptides Product Portfolio
- 4.4.5 Cambridge Research Biochemicals Recent Developments
- 4.5 Bio-Synthesis
- 4.5.1 Bio-Synthesis Company Information
- 4.5.2 Bio-Synthesis Business Overview
- 4.5.3 Bio-Synthesis Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bio-Synthesis Amyloid Peptides Product Portfolio
- 4.5.5 Bio-Synthesis Recent Developments
- 4.6 BioLegend
- 4.6.1 BioLegend Company Information
- 4.6.2 BioLegend Business Overview
- 4.6.3 BioLegend Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BioLegend Amyloid Peptides Product Portfolio
- 4.6.5 BioLegend Recent Developments
- 4.7 Bachem
- 4.7.1 Bachem Company Information
- 4.7.2 Bachem Business Overview
- 4.7.3 Bachem Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bachem Amyloid Peptides Product Portfolio
- 4.7.5 Bachem Recent Developments
- 4.8 AnaSpec, Inc
- 4.8.1 AnaSpec, Inc Company Information
- 4.8.2 AnaSpec, Inc Business Overview
- 4.8.3 AnaSpec, Inc Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AnaSpec, Inc Amyloid Peptides Product Portfolio
- 4.8.5 AnaSpec, Inc Recent Developments
- 4.9 AmideBio
- 4.9.1 AmideBio Company Information
- 4.9.2 AmideBio Business Overview
- 4.9.3 AmideBio Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AmideBio Amyloid Peptides Product Portfolio
- 4.9.5 AmideBio Recent Developments
5 Global Amyloid Peptides Market Scenario by Region
- 5.1 Global Amyloid Peptides Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amyloid Peptides Sales by Region: 2021-2032
- 5.2.1 Global Amyloid Peptides Sales by Region: 2021-2026
- 5.2.2 Global Amyloid Peptides Sales by Region: 2027-2032
- 5.3 Global Amyloid Peptides Revenue by Region: 2021-2032
- 5.3.1 Global Amyloid Peptides Revenue by Region: 2021-2026
- 5.3.2 Global Amyloid Peptides Revenue by Region: 2027-2032
- 5.4 North America Amyloid Peptides Market Facts & Figures by Country
- 5.4.1 North America Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amyloid Peptides Sales by Country (2021-2032)
- 5.4.3 North America Amyloid Peptides Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amyloid Peptides Market Facts & Figures by Country
- 5.5.1 Europe Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amyloid Peptides Sales by Country (2021-2032)
- 5.5.3 Europe Amyloid Peptides Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amyloid Peptides Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amyloid Peptides Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amyloid Peptides Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amyloid Peptides Market Facts & Figures by Country
- 5.7.1 South America Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amyloid Peptides Sales by Country (2021-2032)
- 5.7.3 South America Amyloid Peptides Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Amyloid Peptides Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amyloid Peptides Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amyloid Peptides Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amyloid Peptides Sales by Type (2021-2032)
- 6.1.1 Global Amyloid Peptides Sales by Type (2021-2032) & (g)
- 6.1.2 Global Amyloid Peptides Sales Market Share by Type (2021-2032)
- 6.2 Global Amyloid Peptides Revenue by Type (2021-2032)
- 6.2.1 Global Amyloid Peptides Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amyloid Peptides Revenue Market Share by Type (2021-2032)
- 6.3 Global Amyloid Peptides Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amyloid Peptides Sales by Application (2021-2032)
- 7.1.1 Global Amyloid Peptides Sales by Application (2021-2032) & (g)
- 7.1.2 Global Amyloid Peptides Sales Market Share by Application (2021-2032)
- 7.2 Global Amyloid Peptides Revenue by Application (2021-2032)
- 7.2.1 Global Amyloid Peptides Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amyloid Peptides Revenue Market Share by Application (2021-2032)
- 7.3 Global Amyloid Peptides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amyloid Peptides Value Chain Analysis
- 8.1.1 Amyloid Peptides Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amyloid Peptides Production Mode & Process
- 8.2 Amyloid Peptides Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amyloid Peptides Distributors
- 8.2.3 Amyloid Peptides Customers
9 Global Amyloid Peptides Analyzing Market Dynamics
- 9.1 Amyloid Peptides Industry Trends
- 9.2 Amyloid Peptides Industry Drivers
- 9.3 Amyloid Peptides Industry Opportunities and Challenges
- 9.4 Amyloid Peptides Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst